© 2025 Avenzo Therapeutics, Inc. All Rights Reserved. | Terms of Service | Privacy Notice

For more information about Avenzo Therapeutics’ ongoing clinical trials, please visit the Clinical Trials section of our website. If you have additional questions about our Expanded Access …

Aug 21, 2023 · Mohammad Hirmand, M.D., serves as co-founder, Executive Vice President and Chief Medical Officer (CMO) of Avenzo Therapeutics, responsible for clinical development, …

Dec 11, 2024 · Avenzo Therapeutics to Present Initial Results from the Phase 1 Study of AVZO-021, a Potential Best-in-Class CDK2 Inhibitor, at the 2025 San Antonio Breast Cancer Symposium

Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing next-generation oncology therapies for patients. The company’s lead drug candidate, AVZO-021, is a …

Dec 11, 2025 · Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing next-generation oncology therapies for patients. The company’s pipeline includes …

Mar 26, 2024 · Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing the next generation of oncology therapies for patients. The company’s lead drug …

Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing next-generation oncology therapies for patients. The company’s pipeline includes potential best-in …

Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing next-generation oncology therapies for patients. The company’s pipeline includes potential best-in …

Jan 4, 2024 · Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing the next generation of oncology therapies for patients. The company’s lead drug …